Free Trial

NovoCure (NVCR) Competitors

NovoCure logo
$16.86 +0.38 (+2.31%)
(As of 11/20/2024 ET)

NVCR vs. IRTC, NVRO, BLCO, INSP, PRCT, AXNX, NVST, NARI, TMDX, and LIVN

Should you be buying NovoCure stock or one of its competitors? The main competitors of NovoCure include iRhythm Technologies (IRTC), Nevro (NVRO), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), Axonics (AXNX), Envista (NVST), Inari Medical (NARI), TransMedics Group (TMDX), and LivaNova (LIVN). These companies are all part of the "medical equipment" industry.

NovoCure vs.

iRhythm Technologies (NASDAQ:IRTC) and NovoCure (NASDAQ:NVCR) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, media sentiment, earnings, community ranking, valuation, risk and analyst recommendations.

iRhythm Technologies currently has a consensus price target of $108.50, suggesting a potential upside of 47.14%. NovoCure has a consensus price target of $26.17, suggesting a potential upside of 55.20%. Given NovoCure's higher probable upside, analysts plainly believe NovoCure is more favorable than iRhythm Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
iRhythm Technologies
0 Sell rating(s)
1 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.90
NovoCure
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67

In the previous week, iRhythm Technologies had 4 more articles in the media than NovoCure. MarketBeat recorded 6 mentions for iRhythm Technologies and 2 mentions for NovoCure. iRhythm Technologies' average media sentiment score of 1.06 beat NovoCure's score of 0.67 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
iRhythm Technologies
2 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
NovoCure
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

NovoCure has a net margin of -25.93% compared to iRhythm Technologies' net margin of -26.90%. NovoCure's return on equity of -41.48% beat iRhythm Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
iRhythm Technologies-26.90% -120.86% -17.96%
NovoCure -25.93%-41.48%-12.74%

84.6% of NovoCure shares are held by institutional investors. 0.7% of iRhythm Technologies shares are held by company insiders. Comparatively, 6.3% of NovoCure shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

iRhythm Technologies has higher earnings, but lower revenue than NovoCure. iRhythm Technologies is trading at a lower price-to-earnings ratio than NovoCure, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
iRhythm Technologies$492.68M4.68-$123.41M-$4.86-15.17
NovoCure$509.34M3.58-$207.04M-$1.40-12.04

NovoCure received 69 more outperform votes than iRhythm Technologies when rated by MarketBeat users. However, 66.17% of users gave iRhythm Technologies an outperform vote while only 63.61% of users gave NovoCure an outperform vote.

CompanyUnderperformOutperform
iRhythm TechnologiesOutperform Votes
403
66.17%
Underperform Votes
206
33.83%
NovoCureOutperform Votes
472
63.61%
Underperform Votes
270
36.39%

iRhythm Technologies has a beta of 1.23, indicating that its share price is 23% more volatile than the S&P 500. Comparatively, NovoCure has a beta of 0.71, indicating that its share price is 29% less volatile than the S&P 500.

Summary

NovoCure beats iRhythm Technologies on 10 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NVCR vs. The Competition

MetricNovoCureSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$1.82B$4.41B$5.04B$8.81B
Dividend YieldN/A41.16%5.16%4.07%
P/E Ratio-12.0424.83130.5317.82
Price / Sales3.5847.021,183.8674.55
Price / CashN/A51.8733.6132.53
Price / Book4.974.974.684.68
Net Income-$207.04M$13.76M$119.23M$226.08M
7 Day Performance1.75%-1.08%-1.83%-1.04%
1 Month Performance3.63%0.58%-3.61%1.04%
1 Year Performance37.86%50.91%31.74%26.28%

NovoCure Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NVCR
NovoCure
3.7354 of 5 stars
$16.86
+2.3%
$26.17
+55.2%
+38.3%$1.78B$509.34M-12.041,453
IRTC
iRhythm Technologies
3.2627 of 5 stars
$73.74
-2.3%
$108.50
+47.1%
-11.8%$2.31B$492.68M-15.172,000
NVRO
Nevro
2.9004 of 5 stars
$4.23
-0.2%
$9.10
+115.1%
-74.5%$158.88M$425.17M0.001,215Analyst Upgrade
Gap Down
BLCO
Bausch + Lomb
2.7887 of 5 stars
$19.39
-0.8%
$20.91
+7.8%
+23.2%$6.83B$4.68B-18.4713,300
INSP
Inspire Medical Systems
4.91 of 5 stars
$184.88
+5.0%
$233.58
+26.3%
+29.2%$5.54B$624.80M172.781,011Analyst Upgrade
Positive News
Gap Up
PRCT
PROCEPT BioRobotics
1.5836 of 5 stars
$92.70
-0.9%
$89.50
-3.5%
+180.7%$4.88B$136.19M0.00626
AXNX
Axonics
3.2556 of 5 stars
$70.98
flat
$71.00
+0.0%
N/A$3.63B$366.38M-591.45610News Coverage
NVST
Envista
3.8665 of 5 stars
$20.37
+0.5%
$20.71
+1.7%
-14.3%$3.49B$2.57B0.0012,800
NARI
Inari Medical
3.255 of 5 stars
$49.00
-3.9%
$58.89
+20.2%
-15.9%$2.87B$574.50M-36.301,300Insider Trade
Positive News
TMDX
TransMedics Group
4.4357 of 5 stars
$77.20
-6.9%
$131.80
+70.7%
+10.5%$2.78B$241.62M82.13210Analyst Forecast
Gap Down
LIVN
LivaNova
4.3678 of 5 stars
$50.05
-2.6%
$69.17
+38.2%
+6.8%$2.72B$1.15B122.292,900

Related Companies and Tools


This page (NASDAQ:NVCR) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners